XML 45 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
ASSETS    
Cash and cash equivalents $ 221,807 $ 283,341
Grant funds and other receivables 520,509 68,603
Prepaid expenses and other current assets 67,895 95,320
Total current assets 810,211 447,264
Property and equipment, net (Note 5) 9,612 10,606
Deposits 11,010 11,010
Total assets 830,833 468,880
Current liabilities:    
Accounts payable 740,829 152,653
Accrued expenses (Note 6) 1,917,425 1,851,040
Current portion of notes payable (Note 7) 12,048 12,500
Total current liabilities 2,670,302 2,016,193
Note payable, net of current portion (Note 7) 24,781 27,243
Total liabilities 2,695,083 2,043,436
Commitments (Note 8)
Stockholders’ equity (deficiency):    
Preferred Stock, $.01 par value (Note 9): Authorized shares – 10,000,000 Issued and outstanding shares – 400 and 2,486 March 31, 2020 and December 31, 2019, respectively 376,095 1,932,433
Common stock, $.001 par value: Authorized shares – 600,000,000 Issued and outstanding shares – 13,791,601 and 299,835 at March 31, 2020 and December 31, 2019, respectively 13,792 300
Additional paid-in capital 41,189,070 39,340,224
Accumulated deficit (43,443,207) (42,847,513)
Total stockholders’ equity (deficiency) (1,864,250) (1,574,556)
Total liabilities and stockholders’ equity (deficiency) $ 830,833 $ 468,880